Stock TELO TELOMIR PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Telomir Pharmaceuticals, Inc.

Equities

TELO

US87975F1049

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
6.23 USD -7.57% Intraday chart for Telomir Pharmaceuticals, Inc. +9.30% 0.00%
May. 13 Telomir Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 16 Telomir Pharmaceuticals, Inc. Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
TELOMIR PHARMACEUTICALS, INC. Stock Telomir Pharmaceuticals, Inc.
 200M - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 727B
JOHNSON & JOHNSON Stock Johnson & Johnson
 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
 328B
ABBVIE INC. Stock AbbVie Inc.
 277B
ASTRAZENECA PLC Stock AstraZeneca PLC
 243B
  1. Stock Market
  2. Equities
  3. TELO Stock
  4. Charts Telomir Pharmaceuticals, Inc.
  5. Sector Chart